A Careful, Honest Comparison
ChondroFiller® vs
Knee Replacement
ChondroFiller® is a joint-preserving scaffold for focal cartilage defects with reasonably preserved surrounding tissue. Knee replacement is definitive surgery for end-stage bone-on-bone arthritis. These usually describe different patients — but the consultation question is which one fits your case on imaging.
Reviewed byProf Paul Lee MBBch, FRCS (Tr & Orth), PhDLast reviewed 1 May 2026Quick Answer
ChondroFiller® is not a substitute for knee replacement where replacement is clinically appropriate. It is a regenerative scaffold for a focal cartilage defect in a joint that is still otherwise salvageable. Knee replacement is a definitive operation that removes and replaces the worn joint surface in end-stage arthritis. In the right patient — focal defect, reasonably preserved surrounding cartilage, no diffuse bone-on-bone change — ChondroFiller® may help preserve the joint and delay more invasive surgery. In end-stage disease, replacement is usually the right answer. The choice is decided at consultation with imaging review.
The Headline Difference
ChondroFiller® vs Knee Replacement — the key difference
Knee replacement removes and replaces the worn joint surface with metal and polyethylene implants — it is a definitive, one-off operation for end-stage arthritis with a strong evidence base. ChondroFiller® is something different: a regenerative scaffold placed into a specific cartilage defect, so the body’s own cells can rebuild new tissue over six to twelve months. ChondroFiller® preserves the natural joint; replacement replaces it. They sit at very different points on the cartilage-disease ladder.
Mechanism of Action
How each treatment works
ChondroFiller® is a sterile type I/III collagen scaffold injected as a liquid directly into a mapped cartilage defect under ultrasound guidance. It sets into a gel that occupies the defect within minutes.
The patient’s own cells then migrate into the scaffold and lay down new cartilage matrix over six to twelve months. The natural joint surface is preserved — ChondroFiller® does not remove cartilage, does not drill bone and does not place an implant.
Total or partial knee replacement is a definitive surgical procedure. The worn joint surfaces are removed and replaced with metal and polyethylene implants. The underlying arthritic surface is no longer present.
Modern knee replacements have well-documented long-term outcomes. Most patients experience substantial and durable pain relief and functional improvement.
How Long Results May Last
Duration and number of injections
Tissue formation over 6–12 months
15 to 20 years typically
Direct duration comparison is misleading. ChondroFiller® treats a defect in a joint that still has most of its own surface; replacement is a definitive operation that replaces the surface in end-stage disease. They sit at different points on the treatment ladder.
Treatment Course
Number of injections
Typically one injection course, with the box quantity (one, two or three) decided from MRI. A second ChondroFiller® course is rarely needed if the original tissue establishes; if the underlying joint then progresses to end-stage disease at a future date, replacement may become the right answer.
Knee replacement is a one-off operation. Revision surgery is sometimes needed years later in younger or higher-demand patients, but for most patients a single replacement lasts the rest of their life.
Safety and Infection
Safety considerations
These are very different procedures with very different risk profiles. ChondroFiller® at London Cartilage Clinic is an ultrasound-guided outpatient injection delivered under full sterile technique with routine IV antibiotic cover; the most serious risk is joint infection, which is rare.
Knee replacement is major surgery with the risks inherent in any joint replacement — infection, venous thromboembolism, anaesthetic complications, periprosthetic fracture and a rehabilitation period of weeks to months. Knee replacement is delivered through hospital admission with the standard peri-operative care that surgery requires.
Patient Selection
Who each treatment may suit
Knee replacement is the right answer for end-stage osteoarthritis — bone-on-bone change, severe deformity, persistent symptoms despite conservative measures, and a clinical and imaging picture that supports it. We will say so honestly when this is the case. ChondroFiller® is not an alternative for these patients.
ChondroFiller® is appropriate for patients with a focal cartilage defect on MRI — typically up to around 6 cm² with reasonably preserved surrounding cartilage. It is the right answer for a defined defect in a joint that is otherwise still salvageable. See who is suitable for ChondroFiller?
The middle ground is rarer than it sounds. Many patients who feel they are choosing between the two are clearly on one side or the other on imaging. The conversation at consultation is about reading that imaging together.
Cost and Value
What each treatment costs
At London Cartilage Clinic, ChondroFiller® costs from £3,000 for one box, £5,500 for two and £8,000 for three, all-in. See the ChondroFiller® cost guide. LCC was the first UK clinic to offer ChondroFiller® as an injection.
Private knee replacement in the UK typically costs £15,000–£25,000 depending on the provider, implant type and complexity. NHS knee replacement is available for clinically appropriate cases, though waiting times vary by region.
The cost gap is real, but it is not the primary reason to choose one over the other. The more important comparison is clinical: each treatment is right for a different stage of cartilage disease.
Our Honest Take
When we may recommend each
You have a focal cartilage defect on MRI with reasonably preserved surrounding tissue.
The joint is otherwise still salvageable and a joint-preserving regenerative pathway is a reasonable step.
Surgery has been suggested but the imaging supports a non-surgical scaffold injection being a reasonable first step.
End-stage bone-on-bone osteoarthritis with persistent symptoms despite conservative care.
Significant deformity, instability or mechanical failure of the joint that an injection cannot address.
A clinical and imaging picture that points clearly to definitive surgery as the better answer.
When Each Is The Wrong Answer
When we would not recommend each
End-stage bone-on-bone arthritis where there is no preserved cartilage rim for the scaffold to anchor to and replacement is the clinically appropriate path.
Patients expecting ChondroFiller® to prevent the need for knee replacement — that is not what the treatment can promise.
Active infection or unwillingness to accept the conservative safety protocol.
Focal cartilage defects in otherwise salvageable joints, where a joint-preserving regenerative procedure is the more proportionate first step.
Significant comorbidity that makes major surgery a poor risk-benefit choice, where a less invasive option remains reasonable.
Younger patients with a focal defect, for whom replacing the joint now creates a higher-risk revision picture in the future.
The Bottom Line
In summary
ChondroFiller® and knee replacement sit at very different points on the cartilage-disease ladder. ChondroFiller® is not a substitute where replacement is clinically appropriate — and replacement is overkill where a focal defect can be addressed with a joint-preserving injection. Where the joint is still salvageable, ChondroFiller® can be a reasonable step. Where the disease is end-stage, replacement is usually the right answer. We will tell you honestly which one fits your case.
ChondroFiller® vs Knee Replacement
Frequently asked questions
Can ChondroFiller® help me avoid a knee replacement?
Where the joint is still salvageable — a focal cartilage defect with reasonably preserved surrounding tissue — ChondroFiller® may help preserve the joint and delay more invasive surgery. It is not a substitute where replacement is clinically appropriate, and we will not promise that it prevents the need for surgery in end-stage disease. The right answer depends on the imaging and clinical picture at consultation.
My MRI shows bone-on-bone arthritis. Is ChondroFiller® right for me?
In most cases, no. ChondroFiller® needs reasonably preserved surrounding cartilage and a stable subchondral bone plate for new tissue to form. Diffuse bone-on-bone change is usually the picture where replacement is the right answer and we will say so honestly.
Will ChondroFiller® make a future knee replacement more difficult?
Current evidence does not show that prior ChondroFiller® materially complicates a subsequent knee replacement. The scaffold integrates into the defect; the surgical field for replacement is well established. We will discuss this directly if a future replacement looks likely.
I have been told I need a knee replacement. Should I try ChondroFiller® first?
Sometimes yes, sometimes no. Where the imaging shows a focal defect rather than diffuse end-stage arthritis, ChondroFiller® can be a reasonable step. Where the joint is genuinely end-stage, replacement is the better answer and we will say so honestly rather than offering a regenerative pathway that is unlikely to help.
Is ChondroFiller® available on the NHS?
ChondroFiller® is not routinely funded by the NHS in the UK at this time, and is delivered as a private treatment at London Cartilage Clinic. Knee replacement is a routine NHS procedure for clinically appropriate cases, though waiting times vary. See the ChondroFiller® cost guide for the private-pay context.
Does ChondroFiller® regenerate cartilage or just delay surgery?
ChondroFiller® supports natural cartilage regeneration in a focal defect — the scaffold provides a structure for the patient’s own cells to form new tissue over six to twelve months. Whether that translates to delaying surgery for a given patient depends on the underlying disease and what the joint does over the following years. See the ChondroFiller® clinical evidence page for the outcome data.
Book a ChondroFiller® Assessment – London
Natural cartilage regeneration starts with the right defect, the right operator, and the right plan.
Learn More about ChondroFiller
Deep dive into our clinical resources and patient guides.
Cost in the UK
ChondroFiller® cost in the UK from £3,000, what is included and why prices vary.
Suitability
Who is suitable for ChondroFiller® as an injection, and who may need caution.
Clinical Evidence
IKDC, Harris Hip Score and MOCART MRI outcomes for ChondroFiller® cartilage regeneration.
Self-Assessment
Five-question ChondroFiller® pathway self-assessment for Prevention, Regeneration, Combination, or Support.
In London
Private ChondroFiller® cartilage repair at our Harley Street clinic.
Liquid Cartilage™ Surgery
Our proprietary keyhole-surgery technique combining ChondroFiller® with MSC co-delivery in a single procedure, for larger or more complex cartilage defects. £9,800.
ChondroFiller vs Arthrosamid
Cartilage regeneration vs joint cushioning, two very different injections.
ChondroFiller vs Hyaluronic Acid
Structural scaffold for cartilage regeneration vs joint-lubricant viscosupplement.
ChondroFiller vs Microfracture
ChondroFiller® regeneration compared to microfracture surgery for cartilage defects.
ChondroFiller vs MACI
ChondroFiller® scaffold compared to matrix-induced autologous chondrocyte implantation.
ChondroFiller vs ACI
ChondroFiller® scaffold compared to the original autologous chondrocyte implantation technique.
ChondroFiller vs PRP
ChondroFiller® cartilage regeneration compared to platelet-rich plasma injection.
ChondroFiller vs Stem Cells
ChondroFiller® compared to stem cell and biologic regenerative treatments.
ChondroFiller vs Knee Replacement
Where ChondroFiller® may help preserve the joint and where replacement is the right answer.
ChondroFiller® Injection
Cartilage Regeneration Overview
ChondroFiller® is a registered trademark of Meidrix Biomedicals GmbH. London Cartilage Clinic is not affiliated with or endorsed by Meidrix Biomedicals.